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ABSTRACT
Indo-Pakistani populations have one of the highest risks of
coronary artery disease (CAD) in the world. A population-
based, cross-sectional survey was conducted on 3143
adults aged >40 years from 12 randomly selected
communities in Karachi, Pakistan. Apart from smoking,
women had more CAD risk factors (diabetes, hyperten-
sion, obesity, dyslipidaemia) than men. Definite CAD
(history and Q waves on ECG) was more prevalent in men
than in women (6.1% vs 4.0%; p=0.009). In contrast,
ischaemic and major ECG changes were twice as
prevalent in women as in men (29.4% vs 15.6%, and
21.0% vs 10.5%; p,0.001 for each, respectively). All
measures of CAD were strongly predicted by the
metabolic syndrome, but that failed to account for the
greater prevalence of ECG abnormalities in women than in
men. The findings indicate that one in five middle-aged
adults in urban Pakistan may have underlying CAD.
Women are at greater risk than men.
Trial registration number: NCT00327574
People of Indo-Asian origin have one of the highest
susceptibilities to coronary artery disease (CAD) in
the world,
12and it is therefore unsurprising that
CAD is now the leading cause of death in the Indo-
Pakistan subcontinent.
3
Meta-analysis of previously conducted studies
suggests an almost 2.5-fold rise in the prevalence of
CAD in two decades—from 3.6% in the 1970s to
9.5% in the 1990s in people aged >35 years in
urban India.
4 With increasing urbanisation in the
subcontinent, CAD prevalence can only continue
to rise, and this underlines the need to understand
risks and determinants of disease in this population
to inform preventive strategies.
We and others have reported that unlike
European populations, the burden of cardiovascu-
lar risk factors in Indo-Asians, such as hyperten-
sion, diabetes, dyslipidaemia, obesity, including
central obesity, and physical inactivity, are at least
equivalent if not greater in women than in men.
5–8
Correspondingly, the gender difference in prevalent
CAD may also be attenuated, or even abolished in
Indo-Asians, depending upon the diagnostic cri-
teria employed.
6–9 Population-based studies require
unbiased, non-invasive measures of CAD. In
developing countries, in particular, doctors’ reports
may be biased by gender differences in healthcare
seeking behaviour, referral and diagnostic prefer-
ences. On the other hand, ECG criteria are thought
to be of less prognostic significance in women.
10 11
However, gender differences in prevalent CAD
according to available non-invasive criteria for
diagnosis, and their associations with risk factors,
have not been formally studied in large population
samples from the Indo-Pakistan subcontinent,
making the choice of definition difficult.
We therefore conducted this study to determine
gender differences in the prevalence of CAD using
non-invasive criteria, and their association with
cardiovascular risk factors in a population sample
from Karachi, Pakistan.
METHODS
Ethical approval was obtained from ethics review
committee at the Aga Khan University, Pakistan.
Study design
The study design comprised cross-sectional analy-
sis of a population-based sample studied for
recruitment to a cluster randomised trial of
strategies to control hypertension. (Trial registra-
tion number NCT00327574.) All subjects aged
>40 years and able to give their consent were
included in the study. Poorly mobile patients, those
mentally incompetent and unable to give consent,
or patients who had known advanced liver or
kidney failure or pregnancy were excluded.
Sampling details
The Federal Bureau of Statistics has divided the
city of Karachi into 5000 clusters each of about 250
households. On average, each household contains
seven people, 20% of whom are aged >40 years.
About 85% of all clusters (4200) are in the low-
income group neighbourhoods (average household
income less than $120/month) and were mapped
into 12 geographically contiguous areas of 350
clusters each. One cluster was randomly selected
(computer generated) from each area for inclusion
in the study. A census was done, and a listing of all
people from all households in the selected areas
was made.
Trained community health workers paid home
visits to the selected subjects and invited them to
participate in the study. All subjects were eval-
uated by a rigorously trained field team (compris-
ing field workers, nurses and technicians) after
obtaining informed consent. The evaluation
included the following: (a) history and physical
examination; (b) questionnaire detailing smoking
status, food frequency questionnaire and other
lifestyle factors, self-reported doctor diagnosis of
heart disease, the World Health Organisation Rose
questionnaire
12 for angina, and the international
physical activity questionnaire; (c) assessments of
blood pressure with a calibrated automated device
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Inc, Illinois, USA) in the sitting position after at least
20 minutes of rest; (d) anthropometry (height, weight, waist
and hip circumferences); (e) laboratory tests for risk factors for
cardiovascular disease (CVD) including fasting blood glucose
(Synchron Cx-7/Delta, Beckman, USA), lipid profile
(HITACHI-912, Roche Japan), spot urine microalbumin
((reagent: Pyrogallol Red plus Sodium molybdate, Synchron
Cx-7/Delta) Array Systems, Beckman) and urine creatinine
(Synchron Cx-7/Delta); (f) and a 12-lead electrocardiogram
(ECG) coded to the Minnesota code by a grader in the UK who
was unaware of all information except the participant identity
number. All measurements were performed to a standard
protocol that conforms to the international standards for
definitions and measurements. The study was conducted over
1 year (2004–5).
Statistical analysis
Definitions of CAD used a combination of criteria: definite
CAD (defined as a doctor’s report of a heart attack or Q waves
on ECG (Minnesota codes 1-1 to 1-2)), positive response to Rose
angina questionnaire, ischaemic ECG (Minnesota codes 1-3 or 4-
1 or 4-2 or 4-3 or 5-1 or 5-2 or 5-3 or 7-1), and major ECG
abnormalities (ECG Minnesota codes: 4-1 or 4-2 or 5-1 or 5-2 or
6-1 or 6-2 or 7-1 or 7-2 or 8-1 or 8-3.
13 14)
Hypertension was defined as a mean systolic pressure
>140 mm Hg or a mean diastolic pressure >90 mm Hg
measured 20 minutes apart, on two separate occasions, or
taking antihypertensive drugs.
Diabetes was defined as fasting blood sugar >7.0 mmol/l, or
taking antidiabetic drugs.
15
Overweight and obesity was defined as body mass index of
>23 kg/m
2.
16
Central obesity was defined as a waist circumference
(measured at the mid-point between the iliac crest and the
lower rib margin) of >80 cm in women and >90 cm in men.
17
Metabolic syndrome was defined as the concomitant presence
of at least three of the following: hypertension, high triglycer-
ides (.1.70 mmol/l); or low HDL cholesterol (,1.04 mmol/l in
men or ,1.30 mmol/l in women), impaired glucose tolerance
Table 1 Characteristics of men and women in mid- to low-income communities in Karachi
Variables
All (n=3143)
No (%)
Men (n=1503)
No (%)
Women (n=1640)
No (%) p Value
Age (years), mean (SD) 51.6 (10.8) 51.9 (10.6) 51.3 (11.0) 0.147
Formal schooling status (%)
Middle school (grade 7 or less) 2137 (68.0) 881 (58.6) 1256 (76.6) ,0.001
Higher education (greater than
middle school)
1006 (32.0) 622 (41.4) 384 (23.4)
Physical activity* (METS) median
(25th–75th centile)
577.5 (82.5–1680) 773 (264–2766) 355 (0–1188) ,0.001
Past smoker{, No (%) 319 (10.1) 300 (20.0) 19 (1.2) ,0.001
Body mass index, mean (SD) 25.6 (5.5) 24.3 (4.7) 26.7 (5.8) ,0.001
Overweight/obesity{, No (%) 2113 (67.4) 893 (59.5) 1220 (74.6) ,0.001
Waist circumference, mean (SD) 89.2 (12.5) 91.0 (12.8) 87.7 (12.1) ,0.001
Central obesity1, No (%) 2064 (65.7) 835 (55.6) 1229 (74.9) ,0.001
Waist:hip ratio, median (25th–75th
centile)
0.9 (0.8–0.9) 0.96 (0.90–1.0) 0.86 (0.81–0.91) ,0.001
Glucose fasting (mmol/l), mean (SD) 6.4 (2.8) 6.3 (2.7) 6.6 (2.9) 0.005
Serum cholesterol (mmol/l), mean
(SD)
4.87 (1.02) 4.76 (0.95) 4.96 (1.07) ,0.001
LDL (mmol/l), mean (SD) 2.99 (0.80) 2.94 (0.75) 3.04 (0.83) 0.003
HDL (mmol/l), mean (SD) 1.04 (0.26) 1.00 (0.22) 1.12 (0.28) ,0.001
Total lipids (g/l), mean (SD) 8.4 (1.4) 8.4 (1.5) 8.4 (1.4) 0.554
Triglycerides (mmol/l), mean (SD) 1.80 (1.08) 1.87 (1.19) 1.73 (0.96) 0.001
Cholesterol:HDL ratio, mean (SD) 4.90 (1.39) 5.18 (1.4) 4.6 (1.35) 0.007
Hypertension", No (%) 1341 (44.0) 501 (34.8) 840 (52.3) ,0.001
Diabetes**, No (%) 627 (21.1) 267 (19.4) 360 (23.8) 0.004
Hyperlipidaemia{{, No (%) 1007 (34.9) 420 (30.5) 587 (39.0) ,0.001
High LDL{{, No (%) 868 (30.1) 375 (27.3) 493 (32.7) 0.001
Low HDL11, No (%) 2087 (72.4) 929 (67.5) 1158 (76.9) ,0.001
Hypertrigyceridaemia"", No (%) 1229 (42.6) 595 (43.2) 634 (42.1) 0.535
Metabolic syndrome***, No (%) 1327 (42.2) 487 (32.4) 840 (51.2) ,0.001
*Physical activity MET (metabolic equivalent) score was defined as: total MET2minutes/week = walk (METs2min6days) +
moderate (METs6min6days) + vigorous (METs6min6days).
{Past smoker defined as those who smoked >100 cigarettes in their lifetime.
{Overweight/obesity defined as body mass index >23 kg/m
2.
1Central obesity defined as having a waist circumference of >80 cm in women and >90 cm in men.
"Hypertension defined as mean systolic blood pressure >140 mm Hg or mean diastolic blood pressure >90 mm Hg.
**Diabetes defined as patients taking antihypertensive drugs, or having fasting blood sugar >7.0 mmol/l.
{{Hyperlipidaemia defined as fasting serum cholesterol of >5.18 mmol/l.
{{High LDL defined as LDL >3.37 mmol/l.
11Low HDL defined as HDL ,1.04 mmol/l in men or ,1.30 mmol/l in women.
""Hypertriglyceridaemia defined as serum triglyceride .1.70 mmol/l.
***Metabolic syndrome defined as the concomitant presence of at least three of the following: hypertension, high triglycerides
(.1.70 mmol/l); or low HDL cholesterol (,1.04 mmol/l in men or ,1.30 mmol/l in women), impaired glucose tolerance (fasting
glucose >6.1 mmol/l), or central obesity.
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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was based on the components included in the third report of the
National Cholesterol Education Program (NCEP) guidelines with
the modification for definition of central obesity for South Asian
populations, and levels of blood pressure based on the Joint
National Committee (JNC) VII for diagnosis of hypertension.
18
Physical activity was defined based on metabolic equivalent
(METS) per week collected from the international physical
activity questionnaire.
19
Low level of education was defined as less than 7th grade of
formal school education.
Economic status was measured by monthly income and by
ownership of household items.
Past smokers were defined as those who smoked >100
cigarettes in their life time, but were not currently smoking.
All data analyses were performed in SAS version 9.1.3 (SAS
Institute Inc, Cary, NC, USA). The prevalence of outcomes
(95% CI) was calculated for the studied population, stratified by
sex, after accounting for cluster sampling. Associations between
risk factors and measures of CAD were sought, again stratified
by sex, and multivariable models were built to assess the
independence of such associations. We also combined the sexes
to explore risk factors which might account for gender
differences in CAD outcomes. We performed logistic regression
analysis specific for complex survey designs which accounted
for cluster sampling for the outcomes using various definitions
of CAD: (a) definite CAD; (b) ischaemic ECG changes; and (c)
major ECG abnormalities. For each model, those without the
primary outcome and with other definitions of CAD or a
positive response to the Rose angina questionnaire were
excluded from the analysis. This rationale was used to generate
a comparator group ‘‘clean’’ of possible CAD. Candidate
predictors for these models included sociodemographic variables
such as age, gender, level of education, diet, physical activity,
economic status, smoking status, individual biological risk
factors and the composite measure of the metabolic syndrome.
A forward selection method was used with entry criteria of
p,0.1 for factors associated with CAD, and those with p,0.05
were retained in the final model.
RESULTS
A target sample population of 3546 subjects aged >40 years,
stratified by sex were invited to enrol in the study; 3143 (88.6%)
consented. The mean (SD) age of participants was 51.6 (10.8)
years and 1503 (48%) were men. Table 1 shows the character-
istics of the study population. Women were more likely to have
Table 2 Prevalence of coronary artery disease in urban Pakistan
Variables
All (n=3143)
No (%) (95% CI)
Men (n=1503)
No (%) (95% CI)
Women (n=1640)
No (%) (95% CI) p Value
Ischaemia on ECG*
Q-wave changes{ 68 (2.2) (1.5 to 2.7) 46 (3.1) (1.9 to 4.1) 22 (1.3) (0.7 to 1.9) 0.001
Past history of heart attack diagnosed by doctor 113 (3.6) (2.5 to 4.6) 64 (4.3) (2.8 to 5.6) 49 (3.0) (1.9 to 4.0) 0.068
Past history of heart attack or Q-wave changes
diagnosed by doctor
158 (5.0) (3.8 to 6.1) 97 (6.1) (4.1 to 8.0) 66 (4.0) (3.0 to 5.0) 0.009
Positive Rose angina questionnaire 398 (12.7) (10.8 to 14.5) 134 (8.9) (7.3 to 10.5) 264 (16.0) (13.4 to 18.7) ,0.001
Major ECG abnormalities{ 502 (16.0) (13.1 to 18.7) 158 (10.5) (8.1 to 12.8) 344 (21.0) (16.9 to 25.0) ,0.001
*Ischaemia on ECG: Minnesota codes 1-3 or 4-1 or 4-2 or 4-3 or 5-1 or 5-2 or 5-3 or 7-1.
{Q-wave changes: Minnesota codes 1-1 to 1-2.
{Major ECG abnormalities: Minnesota codes: 4-1 or 4-2 or 5-1 or 5-2 or 6-1 or 6-2 or 7-1 or 7-2 or 8-1 or 8-3.
Table 3 Factors associated with definite coronary artery disease (CAD)* in men and women
Variables
Men Women
All With CAD
Unadjusted
odds ratio
(95% CI)
Adjusted
odds ratio
(95% CI) All With CAD
Unadjusted
odds ratio
(95% CI)
Adjusted
odds ratio
(95% CI)
Subjects, No (%) 1211 90 (7.4) 1011 63 (6.2)
Age (years), mean (SD) 51.3 (10.2) 56.6 (10.4) 1.05 (1.03 to 1.06) 1.03 (1.01 to 1.05) 50.9 (10.3) 56.5 (10.6) 1.02 (1.01 to 1.03) 1.03 (1.01 to 1.04)
Past smoker{, No (%) 300 (94.0) 60.0 (20.0) 3.13 (2.04 to 4.77) 2.64 (1.72 to 4.06) 15 (1.5) 1 (1.6) 0.91 (0.35 to 2.36) NS1
Waist to hip ratio,
mean (SD)
0.94 (0.08) 0.97 (0.07) 1.51 (1.19 to 1.91) NS 0.86 (0.07) 0.90 (0.08) 1.87 (1.41 to 2.48) 1.70 (1.28 to 2.26)
Body mass index,
mean (SD)
24.2 (4.7) 25.5 (4.8) 1.05 (1.01 to 1.10) NS 26.5 (5.7) 26.3 (4.6) 0.99 (0.96 to 1.02) NS
Hypertriglyceridaemia,
No (%)
475 (39.2) 43 (47.8) 1.45 (0.95 to 2.23) NS 387 (38.2) 29 (46.0) 1.40 (0.77 to 2.54) NS
Low LDL, No (%) 443 (36.6) 28 (31.1) 0.76 (0.50 to 1.17) NS 351 (34.7) 18 (28.6) 0.73 (0.50 to 1.08) NS
Low HDL, No (%) 857 (70.7) 62 (68.9) 0.90 (0.62 to 1.31) NS 790 (78.1) 51 (81.0) 1.20 (0.66 to 2.18) NS
Exercise, No (%) 385 (31.8) 19 (21.1) 0.55 (0.31 to 0.95) NS 184 (18.2) 12 (19.1) 1.06 (0.46 to 2.41) NS
Hypertension, No (%) 351 (29.0) 46 (51.1) 2.79 (1.73 to 4.51) 2.25 (1.33 to 3.80) 467 (46.1) 46 (73.0) 3.38 (1.87 to 6.13) 2.73 (1.61 to 4.64)
Diabetes, No (%) 207 (17.0) 30 (33.3) 2.66 (1.99 to 3.56) 2.57 (1.80 to 3.68) 227 (22.4) 26 (41.3) 2.61 (1.37 to 4.95) NS
Metabolic syndrome{
, No (%)
543 (44.8) 55 (61.1) 2.03 (1.45 to 2.85) Not applicable 553 (54.7) 45 (71.4) 2.16 (1.19 to 3.90) Not applicable
*CAD defined as presence of major Q waves on ECG or history of heart attack diagnosed by a doctor.
{Past smokers defined as those who smoked >100 cigarettes in their lifetime.
{Metabolic syndrome defined as the concomitant presence of at least three of the following: hypertension, high triglycerides (.1.70 mmol/l); or low HDL cholesterol (,1.04 mmol/l
in men or ,1.30 mmol/l in women), impaired glucose tolerance (fasting glucose >6.1 mmol/l), or central obesity.
1NS, not significant in the multivariable model and therefore not retained in the final model.
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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cholesterol levels, more likely to be obese, and were much less
likely to be physically active than men. They were, however,
less likely to be current or ex-smokers, and had lower
triglyceride levels. The prevalence of the metabolic syndrome
in women was substantially greater than in men (51.2% vs
32.4%, p,0.001).
Women were less likely than men to have had a previous
diagnosis by a doctor of heart attack (3% versus 4.3%, p=0.07),
and significantly less likely to have Q waves on ECG (1.3% vs
3.1%, p=0.001). In contrast, women were about twice as likely
to return a positive response to the Rose angina questionnaire,
have ischaemic changes on ECG (29.4% vs 15.6%, p,0.001), and
major ECG abnormalities (table 2).
We then compared CVD risk factors in those with definite
CAD (ie, those with Q waves on ECG or previous diagnosis by a
doctor of heart attack), with those with no evidence of CAD on
ECG and a negative response to the Rose angina questionnaire
by gender. Age and hypertension, were positively and indepen-
dently related to definite CAD in both genders, and diabetes in
men, and waist to hip ratio in women (table 3). The amount of
variance explained by the model was similar when the
metabolic syndrome replaced the last three risk factors. The
multivariate odds ratio (OR) for the association between the
presence of the metabolic syndrome and definite CAD was
equivalent in men and women (OR=2.04 (95% CI 1.38 to 3.03)
and OR=2.08 (95% CI 1.13 to 3.829), respectively). Smoking
was related to definite CAD in men but not women, the latter
probably due to the paucity of ever smokers. Interestingly, none
of the lipid measures were independently related to definite
CAD.
Similarly, we compared those with ischaemia on ECG against
those without definite CAD, no major ECG abnormalities, and
a negative response to the Rose angina questionnaire (table 4).
We noted a similar pattern of independent associations with
ischaemia on ECG as we did with definite CAD. Age and
hypertension were positively and independently related to
ischaemic ECG in both genders. Diabetes was only statistically
significant in men, and waist circumference only in women.
When the metabolic syndrome replaced all risk factors (apart
from age), it too was independently associated with ischaemic
ECG in men and women and explained the same amount of the
model variance as the individual CVD risk factors. The
multivariate OR for the association between the presence of
the metabolic syndrome and ischaemic ECG was similar in men
and women (OR=1.71 (95% CI 1.39 to 2.09) and OR=1.51
(95% CI 1.22 to 1.85), respectively).
A similar exercise was performed for major ECG abnormal-
ities as the comparator. As before, the metabolic syndrome
accounted for similar model variance as individual risk factors,
Table 4 Factors associated with ischaemic ECG changes* in men and women
Variables
Men Women
All
With
ischaemia
Unadjusted
odds ratio
(95% CI)
Adjusted
odds ratio
(95% CI) All
With
ischaemia
Unadjusted
odds ratio
(95% CI)
Adjusted
odds ratio
(95% CI)
Subjects, No (%) 1372 251 (18.3) 1011 63 (6.2)
Age (years), mean (SD) 51.3 (10.2) 55.2 (11.6) 1.02 (1.01 to 1.04) 1.02 (1.01 to 1.03) 50.9 53.3 (11.6) 1.02 (1.01 to 1.03) 1.01 (1.00 to 1.03)
Past smoker{, No (%) 264 (19.2) 67.0 (26.7) 1.01 (0.77 to 1.30) 1.36 (0.97 to 1.89) 12 (0.84) 06 (1.2) 1.95 (0.51 to 7.44) NS1
Waist to hip ratio, mean (SD) 0.94 (0.08) 0.96 (0.07) 0.95 (0.85 to 1.05) NS 0.86
(0.07)
0.87 (0.07) 1.28 (1.11 to 1.47) 1.19 (1.02 to 1.38)
Body mass index, mean (SD) 24.3 (4.7) 24.9 (4.6) 1.03 (1.01 to 1.04) NS 26.5 (5.7) 26.8 (5.5) 1.01 (1.00 to 1.01) NS
Hypertriglyceridaemia, No (%) 546 (39.8) 114 (45.4) 1.22 1.02 to 1.47) NS 562 (39.1)204 (41.8) 1.18 (0.91 to 1.54) NS
Low LDL, No (%) 491 (35.8) 76 (30.3) 0.82 (0.71 to 0.94) NS 491 (34.2)158 (32.4) 0.88 (0.75 to 1.03) NS
Low HDL, No (%) 963 (70.2) 168 (66.9) 1.06 (0.90 to 1.24) NS 1127
(78.5)
388 (79.5) 1.09 (0.83 to 1.44) NS
Physical activity 431 (31.4) 65 (25.9) 0.71 (0.59 to 0.86) NS 255 (17.8)83 (17.0) 0.92 (0.67 to 1.26) NS
Hypertension 443 (32.3) 138 (54.9) 2.71 (2.35 to 3.12) 2.81 (2.12 to 3.72) 722 (50.3)301 (61.7) 2.01 (1.53 to 2.64) 1.82 (1.36 to 2.44)
Diabetes 238 (17.5) 61 (24.3) 1.38 (1.15 to 1.65) 1.50 (1.11 to 2.02) 314 (21.8)113 (23.1) 1.12 (0.87 to 1.43) NS
{Metabolic syndrome 630 (45.9) 142 (56.6) 1.74 (1.49 to 2.01) Not applicable 822 (57.2)314 (64.3) 1.56 (1.26 to 1.93) Not applicable
*Major ECG abnormalities defined as the following codes on ECG: Minnesota codes 4-1 or 4-2 or 5-1 or 5-2 or 6-1 or 6-2 or 7-1 or 7-2 or 8-1 or 8-3.
{Past smokers defined as those who smoked >100 cigarettes in their lifetime.
{Metabolic syndrome defined as the concomitant presence of at least three of the following: hypertension, high triglycerides (.1.70 mmol/l); or low HDL cholesterol (,1.04 mmol/l
in men or ,1.30 mmol/l in women), impaired glucose tolerance (fasting glucose >6.1 mmol/l), or central obesity.
1NS, not significant in the multivariable model and therefore not retained in the final model.
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Table 5 Association of gender with ischaemic heart disease
CAD Ischaemia on ECG Major ECG abnormalities
Unadjusted
odds ratio
(95% CI)
Adjusted
odds ratio
(95% CI)
Unadjusted
odds ratio
(95% CI)
Adjusted
odds ratio
(95% CI)
Unadjusted
odds ratio
(95% CI)
Adjusted
odds ratio
(95% CI)
Women 0.82 (0.57 to 1.18) 0.97 (0.69 to 1.36) 2.29 (1.91 to 2.76) 2.43 (1.95 to 3.02) 2.57 (2.04 to 3.24) 2.78 (2.13 to 3.64)
Age (years) 1.04 (1.02 to 1.06) 1.04 (1.02 to 1.05) 1.02 (1.01 to 1.04) 1.02 (1.01 to 1.04) 1.03 (1.02 to 1.04) 1.03 (1.01 to 1.04)
Past smoker* 2.82 (1.81 to 4.41) 2.33 (1.50 to 3.61) 1.00 (0.77 to 1.30) 1.46 (1.10 to 1.95) 0.99 (0.66 to 1.48) 1.49 (0.97 to 2.28)
Metabolic syndrome{ 2.03 (1.44 to 2.85) 2.05 (1.43 to 2.94) 1.73 (1.49 to 2.01) 1.57 (1.35 to 1.84) 1.54 (1.28 to 1.86) 1.37 (1.14 to 1.64)
*Past smokers defined a those who smoked >100 cigarettes in their lifetime.
{Metabolic syndrome defined as the concomitant presence of at least three of the following: hypertension, high triglycerides (.1.70 mmol/l); or low HDL cholesterol (,1.04 mmol/l
in men or ,1.30 mmol/l in women), impaired glucose tolerance (fasting glucose >6.1 mmol/l), or central obesity.
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Heart 2008;94:408–413. doi:10.1136/hrt.2007.120774 411was an independent predictor in both genders, and had an
equivalent impact in men (OR=1.22 (95% CI 1.01 to 1.49)) and
women (OR=1.21 (95% CI 1.02 to 1.44)).
A gender comparison showed that the greater degree of
definite CAD in men could be accounted for by exposure to
smoking, which overwhelmed the contribution made by the
metabolic syndrome (univariate OR in women compared with
men OR=0.82 (95% CI 0.57 to 1.18); multivariate OR=0.97
(95% CI 0.69 to 1.36) (table 5). In contrast, the greater
prevalence of ischaemic ECG and of major ECG changes in
women compared with men could not be accounted for the by
the greater prevalence of the metabolic syndrome, or by its
components, in women (adjusted OR=2.29 and 2.57, respec-
tively) (table 5).
DISCUSSION
As far as we know, this is the first report of a large population-
based study of gender differences in the prevalence and
determinants of CAD in adults from an urban setting in the
Indo-Pakistan subcontinent using doctors’ reports and electro-
cardiographic criteria. The prevalence of CAD, whichever
definition was used, and especially the non-Q wave major
ECG changes, was remarkably higher in this urban population
than in populations of European origin,
13 and rural populations
in the Indo-Pakistan subcontinent.
8
We confirm that definite CAD, based on a doctor’s report and
Q waves on ECG, was twice as prevalent in men as in women.
However, unlike populations of European origin, we not only
show that ischaemic or major ECG changes were highly
prevalent in our population, but that the prevalence was twice
as high in women as in men. Others indicate either similar or
only a modestly increased prevalence of such ECG changes.
14 20
The greater prevalence of CAD in the Indo-Pakistan popula-
tion is likely to be due to a greater susceptibility to the
metabolic syndrome; around a third to a half of these middle-
aged men and women, respectively, were classified as positive
for the metabolic syndrome using current criteria. The greater
prevalence of definite CAD in men is largely due to the effect of
smoking exposure, which owing to its substantially higher
prevalence in men, overwhelms the impact of the greater
prevalence of the metabolic syndrome in women.
Previous studies in the Indo-Pakistan subcontinent have
generally reported combined definite and probable CAD
prevalence, and thus not demonstrated marked gender differ-
ences
7 However, in a study from South India, the prevalence of
T-wave changes was markedly higher in women than in men
(11% vs 2%), reflecting our own observations of a substantially
greater prevalence of ischaemia and major changes on ECG in
women.
6 These changes are not benign, and are thought to be
indicative of myocardial ischaemia, conduction abnormalities
and early repolarisation reflective of structural heart disease. We
show that they are strongly and equally related to the metabolic
syndrome in men and women, in particular the hypertensive
and dysglycaemic components. In addition, previous studies
show that these changes strongly predict events and mortality,
with around a twofold increased risk, even on multivariate
adjustment for the presence of hypertension, diabetes, over-
weight and obesity, dyslipidaemia, and smoking status.
61 4That
the risk prediction is similar in Blacks and Whites suggests that
these abnormalities may well be important mortality predictors
in other ethnic groups such as Indo-Pakistani populations.
20
Moreover, the identification of similar risk factors for definite
CAD as well as ischaemia on ECG in our study suggests that a
common underlying mechanism may be responsible for these
abnormalities in this population. Thus, we suggest that ECG
changes are not benign in women, and indicate that CAD may
be being underdiagnosed in Indo-Pakistani women, as evident
by the discrepancy between gender differences in doctor-
diagnosed heart attack and ECG changes suggestive of
ischaemia.
We sought to account for the greater prevalence of these
changes in women by adjustment for their greater prevalence of
the metabolic syndrome. However, surprisingly this made little
difference to the odds ratio (2.29 to 2.43). Possible explanations
for this are that we have either not properly accounted for our
measured risk factors, or that there is some other unmeasured
CVD risk factor, also highly prevalent in women which makes a
stronger contribution. Support from the former hypothesis
comes from two directions. In the UK, metabolic syndrome, and
specifically insulin resistance, did not account for the greater
CAD mortality in Indo-Pakistani migrants to the UK than in
the general population. But an interaction was also noted
between dysglycaemia and ethnicity on CAD mortality, such
that diabetes increased CAD mortality by 2.78 times in Indo-
Pakistanis, and only 1.46 times in Europeans.
21 The sample was
too small in that study to explore these relationships further. It
is also interesting to note that among the components that
constitute the metabolic syndrome, hypertension appears to be
most closely related to definite CAD as well as ECG changes,
particularly in women. Possibly, the duration of hypertension,
in particular untreated hypertension, which has been shown to
be greater in women than men, accounts for some of the greater
risk of CAD in women. This is consistent with data from China
which suggests that hypertension has the highest attributable
risk of cardiovascular mortality in women.
22
Our study has potential limitations. First, we did not measure
the presence of atherosclerosis or infarct directly. In addition,
doctor-diagnosed heart attacks were not adjudicated. However,
use of ECG is a well-established and validated method for
assessment of ischaemic heart disease in population-based
studies.
13 Second, ECG coding for CAD based on Minnesota
coding has not been specifically validated in Indo-Pakistani
populations. This requires long-term cohort data in such
populations. However, correlations of these ECG changes with
angiographic evidence of CAD, and with mortality have been
well documented in other populations.
14 23 Third, our study was
limited to the population residing in Karachi, an urban area, and
therefore, may not represent the rural population of Pakistan.
However, the epidemic of heart disease is likely to emerge in
urban areas first, and attempts to document and stem the
epidemic should begin here.
24 Further, our findings are
consistent with the recent INTERHEART study, which
identified a high prevalence of CAD in this population.
25 Our
study adds to INTERHEART and other facility-based studies as
our study methodology of a door to door population-based
approach ensured subject selection unbiased by health seeking
behaviour on the part of the subject, or by selective detailed
medical evaluation on the part of the healthcare provider.
25–27
Thus, we believe our rigorous study design, and the stringent,
objective criteria used to define CAD maximise the generalisa-
bility, validity and reproducibility of our findings.
In conclusion, this is the first large-scale population-based
study from the Indo-Pakistan subcontinent, home to one-sixth
of the world’s population, on gender differences in CAD and its
determinants. Our findings indicate that one in four subjects
aged >40 years may have underlying CAD in urban Pakistan.
Increasing age, history of smoking, and the metabolic syndrome
are strongly associated with CAD, and women are at greater
Global burden of cardiovascular disease
412 Heart 2008;94:408–413. doi:10.1136/hrt.2007.120774risk than men. Doctors should be alerted to the high probability
of this condition in Indo-Pakistani women, and further research
conducted on why these women are at especially high risk.
Concerted efforts are needed to reduce the burden of conven-
tional risk factors for CAD, including hypertension, diabetes,
dyslipidaemia, physical inactivity, tobacco use, unhealthy diets
and obesity in this population, and must target both women
and men.
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